Cerus Revenue 2006-2019 | CERS

Cerus revenue from 2006 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Cerus Annual Revenue
(Millions of US $)
2018 $76
2017 $51
2016 $39
2015 $34
2014 $36
2013 $40
2012 $37
2011 $33
2010 $23
2009 $18
2008 $17
2007 $11
2006 $30
2005 $13
Cerus Quarterly Revenue
(Millions of US $)
Q3 2019 $23
Q2 2019 $22
Q1 2019 $22
Q4 2018 $20
Q3 2018 $19
Q2 2018 $19
Q1 2018 $17
Q4 2017 $19
Q3 2017 $13
Q2 2017 $11
Q1 2017 $8
Q4 2016 $12
Q3 2016 $10
Q2 2016 $9
Q1 2016 $8
Q4 2015 $10
Q3 2015 $8
Q2 2015 $9
Q1 2015 $8
Q4 2014 $10
Q3 2014 $10
Q2 2014 $9
Q1 2014 $8
Q4 2013 $9
Q3 2013 $11
Q2 2013 $10
Q1 2013 $10
Q4 2012 $11
Q3 2012 $8
Q2 2012 $9
Q1 2012 $9
Q4 2011 $10
Q3 2011 $9
Q2 2011 $7
Q1 2011 $7
Q4 2010 $6
Q3 2010 $5
Q2 2010 $6
Q1 2010 $6
Q4 2009 $5
Q3 2009 $5
Q2 2009 $4
Q1 2009 $3
Q4 2008 $4
Q3 2008 $4
Q2 2008 $4
Q1 2008 $5
Q4 2007 $2
Q3 2007 $3
Q2 2007 $3
Q1 2007 $2
Q4 2006 $14
Q3 2006 $8
Q2 2006 $6
Q1 2006 $7
Q4 2005 $6
Q3 2005 $7
Q2 2005 $5
Q1 2005 $6
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.543B $0.061B
Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $148.956B 20.58
Abbott Laboratories (ABT) United States $148.320B 27.06
Stryker (SYK) United States $74.970B 25.21
Boston Scientific (BSX) United States $60.924B 28.76
Baxter (BAX) United States $41.636B 25.25
Essilor Luxottica (ESLOY) France $33.188B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.178B 18.93
Terumo (TRUMY) Japan $26.560B 33.15
Lonza Group Ag (LZAGY) Switzerland $25.341B 0.00
Coloplast (CLPBY) Denmark $25.099B 38.73
ResMed (RMD) United States $21.470B 39.61
Smith & Nephew SNATS (SNN) United Kingdom $19.270B 0.00
Sunny Optical Technology (SNPTF) China $19.151B 0.00
Insulet (PODD) United States $11.169B 531.35
Bio-Rad Laboratories (BIO) United States $10.705B 51.38
DiaSorin S.p.A (DSRLF) Italy $7.616B 0.00
William Demant Holdings (WILYY) Denmark $7.531B 0.00
Canopy Growth (CGC) Canada $7.421B 0.00
Perrigo (PRGO) Ireland $7.212B 13.45
Hill-Rom Holdings (HRC) United States $7.115B 20.98
Haemonetics (HAE) United States $5.955B 40.24
Shandong Weigao Medical Polymer (SHWGF) China $5.743B 0.00
GN STORE NORD (GNNDY) Denmark $5.276B 27.26
NuVasive (NUVA) United States $3.869B 30.46
ICU Medical (ICUI) United States $3.704B 24.15
Neogen (NEOG) United States $3.501B 58.58
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.090B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.969B 0.00
Quidel (QDEL) United States $2.961B 28.10
Aurora Cannabis (ACB) Canada $2.855B 0.00
Agios Pharmaceuticals (AGIO) United States $2.471B 0.00
National Vision Holdings (EYE) United States $2.404B 54.25
Cardiovascular Systems (CSII) United States $1.562B 0.00
InMode (INMD) Israel $1.365B 0.00
Aphria (APHA) $1.278B 0.00
AtriCure (ATRC) United States $1.204B 0.00
VAREX IMAGING (VREX) United States $1.154B 23.11
Phibro Animal Health (PAHC) United States $0.983B 18.41
NanoString Technologies (NSTG) United States $0.937B 0.00
TG Therapeutics (TGTX) United States $0.924B 0.00
Lantheus Holdings (LNTH) United States $0.794B 19.84
Eagle Pharmaceuticals (EGRX) United States $0.777B 29.75
Quanterix (QTRX) United States $0.701B 0.00
LeMaitre Vascular (LMAT) United States $0.686B 38.53
PetIQ (PETQ) United States $0.685B 16.70
Omeros (OMER) United States $0.654B 0.00
HEXO (HEXO) $0.589B 0.00
Surmodics (SRDX) United States $0.555B 57.72
OraSure Technologies (OSUR) United States $0.487B 29.22
Owens & Minor (OMI) United States $0.484B 17.91
MacroGenics (MGNX) United States $0.481B 0.00
Organigram Holdings (OGI) Canada $0.420B 0.00
Meridian Bioscience (VIVO) United States $0.400B 13.77
Utah Medical Products (UTMD) United States $0.384B 27.83
BioLife Solutions (BLFS) United States $0.320B 130.50
Zynex (ZYXI) United States $0.313B 35.44
Bovie Medical (APYX) United States $0.271B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.261B 0.00
United Health Products (UEEC) United States $0.246B 0.00
Viemed Healthcare (VMD) United States $0.239B 25.20
Repro-Med Systems (KRMD) United States $0.235B 0.00
Vapotherm (VAPO) United States $0.226B 0.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.172B 0.00
InfuSystems Holdings (INFU) United States $0.158B 796.00
Chimerix (CMRX) United States $0.155B 0.00
Female Health (VERU) United States $0.151B 0.00
Rockwell Medical (RMTI) United States $0.141B 0.00
MTech Acquisition (KERN) United States $0.129B 0.00
Fonar (FONR) United States $0.127B 8.98
Cytosorbents (CTSO) United States $0.122B 0.00
United-Guardian (UG) United States $0.090B 22.77
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Chembio Diagnostics (CEMI) United States $0.073B 0.00
Nephros (NEPH) United States $0.065B 0.00
MRI Interventions (MRIC) United States $0.061B 0.00
Surface Oncology (SURF) United States $0.058B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Senestech (SNES) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.015B 0.00
Valeritas Holdings (VLRX) United States $0.014B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Myomo (MYO) United States $0.008B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00